Clinical Trial Update: Assessment of Potential Interactions Between Cocaine and Tolcapone - 1 [Phase 1]

View source ↗

Summary

An early-phase study funded by NIDA to assess potential interactions between cocaine and the COMT inhibitor tolcapone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• Cocaine (cocaine)
• Tolcapone (tolcapone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: UNKNOWN